UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023292
Receipt number R000017833
Scientific Title The effect of calcium, Vitamin D, and denosumab on osteoporosis and basal metabolism in postmenopausal diabetic women
Date of disclosure of the study information 2016/07/22
Last modified on 2017/01/23 17:29:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of calcium, Vitamin D, and denosumab on osteoporosis and basal metabolism in postmenopausal diabetic women

Acronym

The effect of denosumab on basal metabolism in type 2 diabetic women

Scientific Title

The effect of calcium, Vitamin D, and denosumab on osteoporosis and basal metabolism in postmenopausal diabetic women

Scientific Title:Acronym

The effect of denosumab on basal metabolism in type 2 diabetic women

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus, Osteoporosis

Classification by specialty

Medicine in general Endocrinology and Metabolism Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the change of the basal metabolism, glucose control and bone metabolism in patients with type 2 diabetes by improvement of osteoporosis with Calcium/vitamin D and Denosumab.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Changes of the Basal metabolism, and the marker of the bone metabolism before and after taking Calcium/Vitamin D and denosumab

Key secondary outcomes

Changes of the blood glucose control level, fasting CPR, iPTH, 25hydroxyvitamin D, blood cell count, serum calcium, phosphate and other general examination of blood, and diabetic neuropathy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Calcium / Vitamin D / Magnesium mixed tablet ; Calcium 305mg, Cholecalciferol 0.005mg (200IU), Magnesium carbonate 59.2mg is containing per tablet. Taking 2 tablet / day prior 1 month from Denosumab 60mg injection to subcutaneous, once per 6 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patient of type 2 Diabetes Mellitus
1: More than 50 years of age at the time of obtaining informed consent
2:With osteoporosis
3: At the participation in this study, that document consent is obtained due to free will of the patient's own by sufficient explanation and thorough understanding.
4:Control of blood pressure and blood glucose are relatively stable, and without planning for remarkable change.

Key exclusion criteria

The patients who
Taking drug for osteoporosis
With presence and past history of malignancy.
With other endocrine diseases
With liver dysfunction except fatty liver
With macro proteinuria or with increased serum creatinine level over 2.0mg/dl
Principal investigator of this study has determined to be inappropriate as a subject

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuko Uchigata

Organization

Tokyo Women's Medical University

Division name

Diabetes Center

Zip code


Address

8-1,Kawadacho Shinjyukuku Tokyo 1628666 Japan

TEL

03-3353-8111

Email

uchigata.dmc@twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makiko Ogata

Organization

Tokyo Women's Medical University

Division name

Diabetes Center

Zip code


Address

8-1,Kawadacho Shinjyukuku Tokyo 1628666 Japan

TEL

03-3353-8111

Homepage URL


Email

mogatamd.dmc@twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Mediclcal University

Institute

Department

Personal name



Funding Source

Organization

Diabetes Center, Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学病院糖尿病センター(東京都)


Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 01 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 19 Day

Last follow-up date

2017 Year 04 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 22 Day

Last modified on

2017 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017833


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name